These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2974449)

  • 1. Effect of PGE1 treatment on in vitro thymocyte function of normal and autoimmune mice.
    Whittum-Hudson J; Ballow M; Zurier RB
    Immunopharmacology; 1988; 16(2):71-8. PubMed ID: 2974449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental abnormalities of terminal deoxynucleotidyl transferase positive bone marrow cells and thymocytes in New Zealand mice: effects of prostaglandin E1.
    Whittum J; Goldschneider I; Greiner D; Zurier R
    J Immunol; 1985 Jul; 135(1):272-80. PubMed ID: 3873491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGF beta.
    Schneider A; Thaiss F; Rau HP; Wolf G; Zahner G; Jocks T; Helmchen U; Stahl RA
    Kidney Int; 1996 Jul; 50(1):190-9. PubMed ID: 8807588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide and 15(S)-15 methyl PGE1 correct the T/B lymphocyte ratios of NZB/NZW mice.
    Girard D; Aloisi RM; Bliven ML; Cunningham AC; Otterness IG
    Agents Actions; 1990 Mar; 29(3-4):333-41. PubMed ID: 2339673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis.
    Kelly CJ; Zurier RB; Krakauer KA; Blanchard N; Neilson EG
    J Clin Invest; 1987 Mar; 79(3):782-9. PubMed ID: 2950135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZB/W F1 mouse.
    Clark WF; Parbtani A; McDonald JW; Taylor N; Reid BD; Kreeft J
    Clin Nephrol; 1987 Dec; 28(6):288-94. PubMed ID: 2450713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental regulation of cAMP signaling pathways in thymocyte development.
    Scherer LJ; Diamond RA; Rothenberg EV
    Thymus; 1994-1995; 23(3-4):231-57. PubMed ID: 8525507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of T cell-mediated immune responsiveness of NZB, (NZB x &NZW)F1 hybrid and other murine strains.
    Zinkernagel RM; Dixon FJ
    Clin Exp Immunol; 1977 Jul; 29(1):110-21. PubMed ID: 142594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early activation antigen of murine T cells recognized by monoclonal natural autoantibody NTA204 and the expression on T cells from aged NZB x NZW F1 mice with overt autoimmune disease.
    Ueda G; Hirose S; Shirai T
    Autoimmunity; 1992; 12(2):117-25. PubMed ID: 1319759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of thymic abnormalities in autoimmune-prone (NZW x BXSB) F1 mice.
    Adachi Y; Inaba M; Inaba K; Than S; Kobayashi Y; Ikehara S
    Immunobiology; 1993 Aug; 188(4-5):340-54. PubMed ID: 8244442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
    J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased syngeneic mixed lymphocyte reaction in autoimmune susceptible mice.
    Hom JT; Talal N
    Scand J Immunol; 1982 Feb; 15(2):195-203. PubMed ID: 6213025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of NZB/W ("lupus") mice with 15(S)-15 methyl PGE1.
    Zurier RB; Gionfriddo M; Miller P
    Prostaglandins Med; 1980 Apr; 4(4):281-4. PubMed ID: 7394067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis.
    Zurier RB; Damjanov I; Sayadoff DM; Rothfield NF
    Arthritis Rheum; 1977; 20(8):1449-56. PubMed ID: 144506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction.
    Takahashi HK; Xue D; Iwagaki H; Tamura R; Katsuno G; Yagi T; Yoshino T; Mori S; Nishibori M; Tanaka N
    Clin Immunol; 2005 Apr; 115(1):85-92. PubMed ID: 15870026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of B cells from autoimmune mice to IL-5.
    Umland SP; Go NF; Cupp JE; Howard M
    J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte subpopulations in the thymus of NZB x NZW mice: phenotypic characterization by flow cytofluorometry analysis.
    Dumont F; Habbersett RC
    Clin Exp Immunol; 1982 Jul; 49(1):87-95. PubMed ID: 6982134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.
    Altman A; Theofilopoulos AN; Weiner R; Katz DH; Dixon FJ
    J Exp Med; 1981 Sep; 154(3):791-808. PubMed ID: 6456321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostaglandin E1 on the production of IgM and IgG class anti-dsDNA antibodies in NZB/W F1 mice.
    Yoshikawa T; Suzuki H; Sugiyama E; Tunru IS; Ikemoto M; Hori T; Matsui S; Yamashita N; Kobayashi M
    J Rheumatol; 1993 Oct; 20(10):1701-6. PubMed ID: 8295181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.